Barbara W. Bodem was appointed senior vice president and chief financial officer of Hill-Rom Holdings, Inc. in December 2018. Ms. Bodem joined Hill-Rom from Mallinckrodt Pharmaceuticals, where she served as senior vice president, Finance. Earlier in her career Ms. Bodem worked at Hospira as vice president, Global Commercial Finance, as well as at Eli Lilly and Company, where she held a variety of Finance roles in the U.S. and the U.K., including serving as CFO for Lilly Oncology. Ms. Bodem recently served as a member of the board of directors of Invacare Corporation. She earned her BS in finance and MBA from Indiana University.
Ms. Bodem serves as chair of the audit committee.